Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells

Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells

US Patent 11413311 · Granted Aug 16, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Depot systems comprising glatiramer acetate2025
Depot systems comprising glatiramer acetate2025
Method for suppressing or alleviating primary or secondary progressive multiple 2025
Method for suppressing or alleviating primary or secondary progressive multiple 2025
Depot systems comprising cariprazine or salts thereof2025
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof2025
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-2024
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-2024
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-2024
Process for preparing microparticles containing glatiramer acetate2024
Process for preparing microparticles containing glatiramer acetate2024
Depot systems comprising Cariprazine or salts thereof2024